ContractLicensing Agreement • May 12th, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations • California
[*] = Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Process Development and Manufacturing Services Agreement by and between Bayhill Therapeutics, Inc. and Lonza Biologics, Inc.Process Development and Manufacturing Services Agreement • May 12th, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Process Development and Manufacturing Services Agreement (this “Agreement”) is effective as of March 28, 2008 (the “Effective Date”), by and between Bayhill Therapeutics, Inc., a Delaware corporation (“Client”), and Lonza Biologics, Inc., a Delaware corporation (“LONZA”) (each, a “Party” and together the “Parties”).
Amendment AgreementAmendment Agreement • May 12th, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations
This Agreement (“Amendment Agreement”) is made and effective this 8th day of November 2002, by and between THE BOARD OF TRUSTEES OF THE LELEAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California (“STANFORD”), and BAYHILL THERAPEUTICS, INC., (formerly named Tolerion, Inc.) having a principal place of business at 3400 West Bayshore Road, Palo Alto, CA 94303-4227 (“BAYHILL”).
